This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Oxyrane UK Limited. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2018
Title: Albena Vergilieva Valevska: Innovator in Glycoprotein Research
Introduction
Albena Vergilieva Valevska is a notable inventor based in Astene, Belgium. She has made significant contributions to the field of glycoprotein research, holding 2 patents that focus on innovative methods and enzymes.
Latest Patents
Her latest patents include mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated N-glycans. These inventions provide methods for facilitating mammalian cellular uptake of glycoproteins. The mannosidases developed by Valevska are designed to enhance the efficiency of glycoprotein production and cellular uptake, which can have important implications in biotechnology and medicine.
Career Highlights
Albena Vergilieva Valevska is currently associated with Oxyrane UK Limited, where she continues to advance her research in glycoprotein technologies. Her work is characterized by a commitment to innovation and practical applications in the field.
Collaborations
Valevska collaborates with esteemed colleagues, including Kathleen Camilla Telesphore Alida Maria Piens and Wouter Vervecken. These partnerships enhance her research capabilities and contribute to the advancement of their shared goals in glycoprotein research.
Conclusion
Albena Vergilieva Valevska is a pioneering inventor whose work in glycoprotein research is paving the way for new advancements in biotechnology. Her contributions are significant and continue to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile